Status:
TERMINATED
Evaluation of Lung Doppler Signals in Pulmonary Hypertension
Lead Sponsor:
Echosense Ltd.
Collaborating Sponsors:
Sheba Medical Center
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the lung Doppler signals in patients with pulmonary hypertension that undergo (prospective arm) or underwent (retrospective arm) right heart catheterization (R...
Detailed Description
PROTOCOL SUMMARY Title: Evaluation of lung Doppler signals (LDS) in pulmonary hypertension (PHTN) Device: SONARA/tek transcranial Doppler (TCD) system Study Objectives: To evaluate the LDS in patient...
Eligibility Criteria
Inclusion
- Prospective arm:
- Man or woman aged over 18.
- With suspicion or diagnosis of pulmonary hypertension.
- Scheduled to undergo right heart catheterization
- Able and willing to give informed consent.
- Retrospective arm:
- Man or woman aged over 18.
- With diagnosis of pulmonary hypertension confirmed by right heart catheterization in the past.
- Able and willing to give informed consent.
Exclusion
- Both arms:
- Minor (aged \< 18).
- People unable or unwilling to give informed consent.
- Hemodynamically unstable patients.
- Pregnant women.
- Prospective arm only:
- Patients with contra-indication to right heart catheterization.
- Patients incapable of performing a Valsalva maneuver.
- Patients with recent myocardial infarction, high degree AV block, severe aortic stenosis or glaucoma
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2017
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01839786
Start Date
May 1 2013
End Date
February 1 2017
Last Update
March 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center, Pulmonology department
Ramat Gan, Israel